Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Fast-Track Versus Standard Care for Persons With HIV Initiating Tenofovir Disoproxil Fumarate-Lamivudine-Dolutegravir (TLD) in Haiti: A Pilot Randomized Trial

NCT04311944 is registered in ClinicalTrials.gov with Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic as lead sponsor.

NCT NCT04311944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04311944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Fast-Track Versus Standard Care for Persons With HIV Initiating Tenofovir Disoproxil Fumarate-Lamivudine-Dolutegravir (TLD) in Haiti: A Pilot Randomized Trial
Lead sponsor
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2020
Completion date
May 29, 2022
Enrollment
242 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection